rs375401655
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000333590.6(PIGA):āc.61A>Gā(p.Ser21Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000231 in 1,209,612 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S21I) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000333590.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIGA | NM_002641.4 | c.61A>G | p.Ser21Gly | missense_variant | 2/6 | ENST00000333590.6 | NP_002632.1 | |
PIGA | NM_020473.3 | c.13+3631A>G | intron_variant | NP_065206.3 | ||||
PIGA | NR_033835.1 | n.177A>G | non_coding_transcript_exon_variant | 2/6 | ||||
PIGA | NR_033836.1 | n.173+4A>G | splice_donor_region_variant, intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIGA | ENST00000333590.6 | c.61A>G | p.Ser21Gly | missense_variant | 2/6 | 1 | NM_002641.4 | ENSP00000369820 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000625 AC: 7AN: 111976Hom.: 0 Cov.: 24 AF XY: 0.0000586 AC XY: 2AN XY: 34134
GnomAD3 exomes AF: 0.0000164 AC: 3AN: 182935Hom.: 0 AF XY: 0.0000297 AC XY: 2AN XY: 67417
GnomAD4 exome AF: 0.0000191 AC: 21AN: 1097636Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 5AN XY: 362994
GnomAD4 genome AF: 0.0000625 AC: 7AN: 111976Hom.: 0 Cov.: 24 AF XY: 0.0000586 AC XY: 2AN XY: 34134
ClinVar
Submissions by phenotype
not provided Uncertain:3Benign:1
Uncertain significance, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 10, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 15, 2018 | - - |
Multiple congenital anomalies-hypotonia-seizures syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 25, 2023 | This sequence change replaces serine, which is neutral and polar, with glycine, which is neutral and non-polar, at codon 21 of the PIGA protein (p.Ser21Gly). This variant is present in population databases (rs375401655, gnomAD 0.001%). This variant has not been reported in the literature in individuals affected with PIGA-related conditions. ClinVar contains an entry for this variant (Variation ID: 430403). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PIGA protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2017 | The p.S21G variant (also known as c.61A>G), located in coding exon 1 of the PIGA gene, results from an A to G substitution at nucleotide position 61. The serine at codon 21 is replaced by glycine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at